The Future of Real-World Evidence (RWE) in Post-Market Clinical Research
The Future of Real-World Evidence (RWE) in Post-Market Clinical Research
13 Jul 2026
Thersaly: Clinical Research Consulting, Reimagined.
Subscribe below to never miss an update.
Latest episodes
Biomarkers in Clinical Trials: Accelerating Oncology and Rare Disease Drug Development
Biomarker-driven clinical trials dramatically increase the probability of regulatory success. Learn how biopharma sponsors leverage companion diagnostics to accelerate oncology and rare disease development.
13 Jul 2026
Building a Winning Clinical Development Plan (CDP) for Investor Readiness
Securing Series A or B biotech funding requires more than brilliant science. Learn how to architect a Clinical Development Plan (CDP) that aligns regulatory strategy with investor value inflection points.
13 Jul 2026